Risankizumab Shows Efficacy in Patients With Active Psoriati

Efficacy results support long-term use of risankizumab in patients with active psoriatic arthritis across multiple patient and psoriatic disease characteristics.

Related Keywords

, American College Of Rheumatology , American College , Psoriasis Area Severity Index , Minimal Disease Activity , Low Disease Activity , Risankizumab Efficacy , Active Psoriatic Arthritis ,